Advanced Medical Solutions Group plc (FRA:AQA)

Market Cap	542.32M +8.3%
Revenue (ttm)	262.43M +29.0%
Net Income	11.41M +40.3%
EPS	0.05 +39.1%
Shares Out	n/a
PE Ratio	47.53
Forward PE	17.11
Dividend	0.03 (1.35%)
Ex-Dividend Date	May 28, 2026

Volume	n/a
Open	2.460
Previous Close	2.440
Day's Range	2.460 - 2.460
52-Week Range	2.180 - 3.000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 16, 2026

About FRA:AQA

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. The company operates in two segments, Surgical and Woundcare. It offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, infection control, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G, Vitalitec, and Acti...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1991
• Employees: 1,800
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: AQA

Financial Performance

In 2025, FRA:AQA's revenue was 228.94 million, an increase of 28.96% compared to the previous year's 177.52 million. Earnings were 9.95 million, an increase of 40.32%.

Financial numbers in GBP